The Rockefeller Cancer Institute’s Center is the worldwide leader in Myeloma Treatment and is proud to announce that its five-year survival rates are greater than 74%—nearly twice the average of any other treatment facility in the United States.
Areas of Excellence
(More)
Oct. 16, 2024, | The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has been designated as a Center of Excellence by the MDS Foundation, making it the only center in Arkansas to become part of the foundation’s referral network of the top bone marrow disorder treatment centers in the world.
| CAR T-cell Therapy | (Learn More) |
| Chemotherapy | (Learn More) |
| Hormone Therapy | (Learn More) |
| Immunotherapy | (Learn More) |
| Radiation Therapy | (Learn More) |
| Stem Cell Transplantation | (Learn More) |
| Quality of Life Management | (Learn More) |
(Learn More)
(Learn More)
The Lung Cancer Center at the Winthrop P. Rockefeller Cancer Institute offers the most advanced lung cancer treatment in the country.
Just as each person is unique, so is each cancer diagnosis. That’s why the lung cancer team at the UAMS Winthrop P. Rockefeller Cancer Institute treats each patient with personalized care. Our expert team members include surgeons, radiation oncologists, medical oncologists, radiologists, pulmonologists, nurses, smoking cessation counselors, social workers, and others.
The lung cancer team meets weekly to discuss each patient’s condition and determine the best course of treatment. Then, they work together to ensure treatment is carried out and side effects are as limited as possible. The team’s goal is to help each patient maintain the best possible quality of life during and after treatment.
(Learn More)
At Winthrop P. Rockefeller Cancer Institute, our subspecialists are world-renowned leaders in diagnosing and treating even the most complex and aggressive cases of colon, rectal, and anal cancers, as well as hereditary colorectal cancer syndromes, including familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (Lynch syndrome).
With advanced technology and precise techniques, including minimally invasive robotic and laparoscopic surgery and short-course radiation and proton therapy, our goal is to provide patients with the best possible chance for a quick recovery and a positive outcome.
(Learn More)
The Head and Neck Cancer Center at the Winthrop P. Rockefeller Cancer Institute provides the most advanced treatment with state-of-the-art equipment for all types of malignant and benign head and neck tumors.
Doctors in the Head and Neck Oncology Center work closely with our other cancer specialists, such as radiation oncologists and medical oncologists, to decide the best treatment plan available for you. Should you require reconstructive surgery, a surgeon with extensive reconstruction experience is available to see you in the same building as our clinic.
(Learn More)
The Urology Oncology Cancer Center at the Winthrop P. Rockefeller Cancer Institute provides the most advanced services in the southern United States for men and women with urologic cancers, including:
Doctors in the Head and Neck Oncology Center work closely with our other cancer specialists, such as radiation oncologists and medical oncologists, to decide the best treatment plan available for you. Our doctors are among the few highly qualified surgeons in the southern United States with the expertise to provide minimally invasive robotic surgery.
(Learn More)
The Women’s Cancer Center at the Winthrop P. Rockefeller Cancer Institute offers compassionate support and comprehensive treatment options for all types of gynecologic cancers, including:
(Learn More)
The Winthrop P. Rockefeller Cancer Institute has been accredited byThe Stem Cell Transplantation and Cellular Therapy Program is FACT accredited and meets the most rigorous standards in every aspect of stem cell therapy, from clinical care and donor management to cell collection, processing, storage, transportation, administration and cell release.
(Learn More)
Dec. 15, 2023, | The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute continues to make progress on achieving National Cancer Institute (NCI) designation, a recognition given to cancer centers that meet rigorous standards for state-of-the-art research, cancer prevention, and treatment.
The world-renowned Myeloma Center sets UAMS apart in research and clinical care, making it the crown jewel of the translational science component of the NCI application.
Under the leadership of Director Michael Birrer, M.D., Ph.D., the Cancer Institute has focused largely on recruiting top research and clinical talent from across the country, hiring 25 new researchers and seven oncologists in the last two years.
(Learn More)
Winthrop (Win) P. Rockefeller served as Arkansas’ lieutenant governor from 1996 until his death in 2006. The sons of former Arkansas Gov. Winthrop Rockefeller and the great-grandson of John D. Rockefeller, founder of Standard Oil, Rockefeller, and his father were committed to helping Arkansas develop and expand its capacity to serve its citizens.
Win was diagnosed with a myeloma disorder in 2005, which resulted in his decision to establish the Winthrop Rockefeller Cancer Institute. Fast-forward to 2024, and the Rockefeller Cancer Institute’s Center is now the worldwide leader in Myeloma Treatment. It is proud to announce that its five-year survival rates are greater than 74%—nearly twice the average of any other treatment facility in the United States.
(Learn More)
(Learn More)
Please be aware that the services offered on this platform are with U.S. physicians via a virtual 2nd opinion service. Diagnosis may differ when the physician has had the opportunity to provide an in-person examination. The absence of the in-person examinations can affect the accuracy of the diagnosis and resulting opinion. Please also be aware that a virtual 2nd opinion will not establish a provider-patient relationship. The provide patient relationship can only be established when the patient signs a consent to treatment form in the physician’s physical clinic location in the United States.
